Financials

  • Market Capitalization 10.4 B
  • Employee 295
  • Founded 2016
  • CEO N/A
  • Website www.krystalbio.com
  • Headquarter Pennsylvania, United States
  • FIGI BBG00HDGRHH7
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
36.04
Rapporto prezzo/fatturato
18.98

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
870
SMMT
Summit Therapeutics Inc. - Common Stock
13.73 USD-4.19%+5.05%+7.35%-30.87%10.95 B USD
889
AXSM
Axsome Therapeutics, Inc. - Common Stock
199.02 USD-3.51%-3.86%-13.19%+52.86%10.42 B USD
910
IONS
Ionis Pharmaceuticals, Inc. - Common Stock
61.05 USD-2.21%+0.74%+13.22%-15.36%10.15 B USD
918
CYTK
Cytokinetics, Incorporated - Common Stock
72.09 USD-7.46%-6.75%-8.04%+24.08%10.02 B USD

Notizie